Engineered albumin helps a therapeutic protein last longer and cross mucosal barriers
Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the bloodstream. For patients who depend on long-term or lifelong treatment, frequent injections place a considerable burden on everyday life.
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.
